SynbioBeta is the perfect time to start a conversation about your CRISPR license. We are excited to connect with companies who can benefit from this game-changing technology.
A meeting or a call with us is worthwhile for you if:
You utilise CRISPR/Cas9 for Industrial Bio-production for applications such
as: Cultivated Food, Biofuels, Unique materials and plastics, Dyes/flavors/fragrances, microbes, enzymes, synthetic biology & sequencing tools.
You are interested in use of genetically modified cells in manufacturing of mAbs or
viral vectors.
You provide services which utilise CRISPR/Cas9 or cells or animals modified by the
technology. I ncluding: High-throughput screening, Target identification,
Target validation, oligomer writing/synthesis tools, bio validation of AI
platforms.
When it comes to the CRISPR/Cas9 patent licensing landscape there is a lot of misinformation in circulation. Here, we provide straightforward answers to some of the most common misperceptions…
The application of CRISPR/Cas9 provides a novel platform in the development of recombinant viral vaccines through improvements in vaccine design and experimental vaccination approaches across…
Monoclonal antibodies (mAbs), as well as their derivative products including antibody-drug conjugates, Fc-fusion proteins, and antibody fragments, are well recognized for their vast range of therapeutic and diagnostic uses…